Heterodimeric IgG1 pI Tuning for Homodimer Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing heterodimeric antibodies result in significant production of undesirable homodimers, necessitating complex purification steps, and there is a need to extend the serum half-life of antibodies by altering the constant domains without affecting antigen binding affinity or immunogenicity.
Innovation Solution
Engineer heterodimeric antibodies with variant heavy and light chain constant regions that have isoelectric points at least 0.5 logs apart, allowing for purification by ion exchange chromatography and incorporating specific amino acid substitutions to reduce pI and enhance serum half-life.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods are used to produce heterodimeric antibodies, then production is straightforward, but significant amounts of undesirable homodimers are produced requiring difficult purification steps
Solution Approach 1:
The patent introduces distinct amino acid substitutions at specific locations in the constant regions of heavy and light chains (e.g., position 214 in heavy chain, position 22 in light chain for IgG1). These localized modifications create different isoelectric points for heterodimers versus homodimers, enabling selective purification while maintaining overall antibody structure and function.
Solution Approach 2:
The invention deliberately alters the isoelectric point parameter of the antibody constant regions through amino acid substitutions. By changing charge distribution in the Fc region, the patent creates a physical-chemical parameter difference between heterodimers and homodimers that can be exploited for purification via ion exchange chromatography or isoelectric focusing.
2Ease of manufacture
If purification steps are simplified, then production cost decreases, but heterodimers cannot be separated from homodimers effectively
Solution Approach 1:
The patent modifies the isoelectric point of constant regions through targeted amino acid substitutions, creating a measurable physical-chemical parameter difference between heterodimers and homodimers. This enables the use of standard ion exchange chromatography or isoelectric focusing techniques to achieve effective separation with simplified purification protocols.
Solution Approach 2:
The invention replaces complex multi-step purification mechanical processes with a single-step chromatographic separation based on charge differences. By substituting amino acids to create isoelectric point variations, the patent enables purification through standard ion exchange resins rather than requiring elaborate mechanical separation systems.
3Duration of action of stationary object
If serum half-life is extended by altering constant domains, then antibody persistence increases, but antigen binding affinity or immunogenicity may be affected
Solution Approach 1:
The patent divides the antibody into functional segments: variable regions that maintain antigen binding and constant regions that control serum half-life. By introducing amino acid substitutions specifically in the constant region Fc domain (e.g., positions 214, 217, 228 in heavy chain), the invention allows independent optimization of half-life without compromising variable region binding function.
Solution Approach 2:
The invention applies localized amino acid modifications specifically in the Fc region of constant domains rather than throughout the entire antibody. These site-specific substitutions (e.g., at positions 214, 217, 228 of heavy chain or 22 of light chain for IgG1) alter isoelectric point and half-life properties while leaving antigen-binding variable regions untouched, thereby maintaining binding affinity and reducing immunogenicity risk.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates high-yield purification of desired heterodimers and extends serum half-life by reducing immunogenicity and improving pharmacokinetic properties.
Implementation Method 1
purification by ion exchange chromatography
Data Source
AI summary
The invention relates generally to compositions and methods for purifying the desired species from a mixture of desired heterodimer and contaminating homodimer immunoglobulin variants by modifying the isoelectric point(s) of the individual chains.